Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-06-02 Sale |
2023-06-02 7:15 pm |
Mirati Therapeutics Inc. | MRTX | Stelzer Laurie Chief Financial Officer |
4,647 | $37.06 | $172,218 | 80,015 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2025-02-06 9:22 pm |
N/A 2034-11-13 |
Sionna Therapeutics Inc. | SION | Stelzer Laurie Director |
0 | $0 | 44,480 (Direct) |
View |
| 2024-06-06 Option Award |
2024-06-10 4:44 pm |
N/A 2034-06-05 |
PMV Pharmaceuticals Inc. | PMVP | Stelzer Laurie Director |
67,500 | $0 | 67,500 (Direct) |
View |
| 2024-05-14 Option Award |
2024-05-16 4:10 pm |
N/A 2034-05-14 |
Spyre Therapeutics Inc. | SYRE | Stelzer Laurie Director |
11,323 | $0 | 11,323 (Direct) |
View |
| 2023-11-22 Option Award |
2023-11-27 4:33 pm |
N/A 2033-11-22 |
Spyre Therapeutics Inc. | AGLE | Stelzer Laurie Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2023-08-09 Option Award |
2023-08-10 4:26 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Stelzer Laurie Chief Financial Officer |
22,297 | $37 | 102,312 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-12 5:55 pm |
N/A 2033-06-07 |
PMV Pharmaceuticals Inc. | PMVP | Stelzer Laurie Director |
21,500 | $0 | 21,500 (Direct) |
View |
| 2023-01-20 Option Award |
2023-01-24 4:00 pm |
N/A 2033-01-20 |
Mirati Therapeutics Inc. | MRTX | Stelzer Laurie CFO |
72,320 | $0 | 130,118 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 8:00 pm |
N/A 2032-06-08 |
Surface Oncology Inc. | SURF | Stelzer Laurie Director |
24,000 | $0 | 24,000 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 5:59 pm |
N/A 2032-06-01 |
PMV Pharmaceuticals Inc. | PMVP | Stelzer Laurie Director |
19,500 | $0 | 19,500 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-03 5:56 pm |
N/A 2032-05-31 |
Mirati Therapeutics Inc. | MRTX | Stelzer Laurie CFO |
148,962 | $0 | 148,962 (Direct) |
View |
Ownership |
2022-05-16 5:01 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Stelzer Laurie CFO |
0 | $0 | 0 (Direct) |
View |
| 2022-03-11 Other |
2022-03-11 4:12 pm |
N/A N/A |
ARENA PHARMACEUTICALS INC | ARNA | Stelzer Laurie EVP & Chief Financial Officer |
37,208 | $0 | 37,208 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 5:00 pm |
N/A N/A |
ARENA PHARMACEUTICALS INC | ARNA | Stelzer Laurie EVP & Chief Financial Officer |
21,462 | $0 | 36,366 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-10 4:30 pm |
N/A 2031-06-08 |
Surface Oncology Inc. | SURF | Stelzer Laurie Director |
17,700 | $0 | 17,700 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-09 5:39 pm |
N/A 2031-06-01 |
PMV Pharmaceuticals Inc. | PMVP | Stelzer Laurie Director |
16,333 | $0 | 16,333 (Direct) |
View |
| 2021-03-16 Exercise |
2021-04-02 8:10 pm |
N/A 2022-01-03 |
ARENA PHARMACEUTICALS INC | ARNA | Stelzer Laurie EVP & Chief Financial Officer |
12,600 | $0 | 14,904 (Direct) |
View |
| 2021-03-16 Tax Withholding |
2021-04-02 8:10 pm |
N/A N/A |
ARENA PHARMACEUTICALS INC | ARNA | Stelzer Laurie EVP & Chief Financial Officer |
4,356 | $76.1 | 14,904 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-03 9:33 pm |
N/A 2028-03-01 |
ARENA PHARMACEUTICALS INC | ARNA | Stelzer Laurie EVP & Chief Financial Officer |
60,710 | $0 | 60,710 (Direct) |
View |
Ownership |
2020-09-24 7:21 pm |
N/A 2030-08-11 |
PMV Pharmaceuticals Inc. | PMVP | Stelzer Laurie Director |
0 | $0 | 32,667 (Direct) |
View |
| 2020-06-10 Option Award |
2020-06-12 08:00 am |
N/A 2030-06-10 |
Surface Oncology Inc. | SURF | Stelzer Laurie Director |
12,000 | $0 | 12,000 (Direct) |
View |